Fox Chase Cancer Center News

PHILADELPHIA (September 8, 2021)—Researchers at Fox Chase Cancer Center have identified a molecular circuit that plays a key role in regulating gut immunity. The researchers say the discovery could be a first step in the development of new therapies for colitis, inflammatory bowel disease (IBD), and other disorders.

PHILADELPHIA (September 7, 2021) - Fox Chase Cancer Center is delighted to unite with communities across the country to support the National Ovarian Cancer Coalition (NOCC) for its national Together in Teal event. To donate, participate, or learn more about the Temple Health-Fox Chase Cancer Center team, click here.

PHILADELPHIA (September 6, 2021) – Fox Chase Cancer Center is pleased to announce the hiring of Lu Chen, PhD, who will join the Cancer Signaling and Epigenetics Program and the Cancer Epigenetics Institute (CEI) as an assistant professor.

PHILADELPHIA (September 2, 2021)—Fox Chase Cancer Center is proud to announce the 2021 Philadelphia Walk to End Colon Cancer, a family-friendly fundraising event organized by the Colorectal Cancer Alliance.

PHILADELPHIA (September 1, 2021) – Fox Chase Cancer Center is pleased to announce the hiring of Melissa McShane, MD, who will join the Breast Cancer Medical Oncology Program as an attending physician.

PHILADELPHIA (August 31, 2021)—Researchers at Fox Chase Cancer Center have developed a protocol for procedures to isolate and purify differentiated tumor cells from medulloblastoma in mice and precisely inject these live tumor cells into mouse cerebella.

PHILADELPHIA (August 27, 2021)—Researchers at Fox Chase Cancer Center recently published a study that found that lower levels of trust in community and healthcare sources plays a role in uptake of the vaccine for the human papillomavirus (HPV) vaccine among racial and ethnic minorities in the United States.

PHILADELPHIA (August 24, 2021)—Fox Chase Cancer Center and the Marvin and Concetta Greenberg Pancreatic Cancer Institute were recently renewed as a Clinical Center of Excellence and named for the first time as an Academic Center of Excellence for Pancreatic Cancer by the National Pancreas Foundation.